Mirna Therapeutics (MIRN) Financials

$62.9 M

Mkt cap, 25-May-2018

$354 K

Revenue Q1, 2018
Net income (Q1, 2018)-11.2 M
EBIT (Q1, 2018)-11.6 M
Cash, 31-Mar-201827.2 M

Revenue/Financials

Income Statement

Annual

USDFY, 2015FY, 2016FY, 2017

Revenue

2.4 m

R&D expense

18.9 m13.9 m30.3 m

General and administrative expense

6.1 m8.1 m12.9 m

Operating expense total

25 m22 m43.3 m

EBIT

(40.8 m)

EBIT margin, %

(1670%)

Interest expense

57 k

Interest income

44 k350 k

Net Income

(25 m)(26.3 m)(40.4 m)

Quarterly

USDQ3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2018

Revenue

354 k

R&D expense

4.5 m3.7 m3.4 m8.4 m

General and administrative expense

1.6 m2.1 m2 m1.9 m3.6 m

Operating expense total

6.2 m6.7 m5.7 m5.3 m12 m

EBIT

(11.6 m)

EBIT margin, %

(3287%)

Interest expense

8 k14 k

Interest income

82 k93 k97 k

Net Income

(6.2 m)(6.6 m)(5.6 m)(5.4 m)(11.2 m)

Balance Sheet

Annual

USDFY, 2015FY, 2016FY, 2017

Cash

89.7 m16.4 m58.4 m

Inventories

793 k882 k

Current Assets

90.5 m61.4 m88.6 m

PP&E

375 k354 k9.8 m

Total Assets

90.9 m64.2 m99.7 m

Accounts Payable

3.7 m361 k2.7 m

Current Liabilities

5.9 m2.8 m9 m

Non-Current Liabilities

5.6 m

Total Liabilities

3.8 m

Additional Paid-in Capital

161.5 m163.1 m156.7 m

Retained Earnings

(76.5 m)(102.8 m)(71.7 m)

Total Equity

85 m60.4 m

Financial Leverage

1.1 x1.1 x

Quarterly

USDQ3, 2015Q1, 2018

Cash

35.7 m27.2 m

Current Assets

36.1 m127.9 m

PP&E

266 k13.7 m

Total Assets

38.1 m142.7 m

Accounts Payable

2.2 m1.3 m

Current Liabilities

5 m7 m

Non-Current Liabilities

6.9 m

Additional Paid-in Capital

211.4 m

Retained Earnings

(67.7 m)(82.5 m)

Total Equity

128.8 m

Financial Leverage

1.1 x

Cash Flow

Annual

USDFY, 2015FY, 2016FY, 2017

Net Income

(25 m)(26.3 m)(40.4 m)

Depreciation and Amortization

54 k159 k2.3 m

Inventories

793 k107 k

Accounts Payable

3.7 m(3.3 m)4.1 m

Cash From Operating Activities

(21.1 m)(24.8 m)

Purchases of PP&E

(251 k)(1.7 m)(2.6 m)

Cash From Investing Activities

(251 k)(48.5 m)

Cash From Financing Activities

67 k16 k

Interest Paid

35 k

Quarterly

USDQ3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q1, 2018

Net Income

(6.2 m)(6.6 m)(5.6 m)(5.4 m)(11.2 m)

Depreciation and Amortization

681 k

Accounts Payable

2.2 m1.2 m1.5 m1.2 m371 k47 k(3 m)

Cash From Operating Activities

(13 m)

Purchases of PP&E

(1.9 m)

Cash From Investing Activities

(71.9 m)

Cash From Financing Activities

53.6 m

Interest Paid

14 k

Ratios

USDY, 2018

Financial Leverage

1.1 x
Report incorrect company information

Operating Metrics

FY, 2016

Patents Issued

10

Patents Pending

42
Report incorrect company information